Literature DB >> 18760488

Adherence to continuation and maintenance antidepressant use in recurrent depression.

Mascha C ten Doesschate1, Claudi L H Bockting, Aart H Schene.   

Abstract

BACKGROUND: In chronic diseases adherence is a problem. Little is known about adherence to antidepressants after the acute phase in recurrent depression. This study evaluates adherence to antidepressants in the continuation and maintenance phase in remitted recurrently depressed patients.
METHODS: We prospectively assessed adherence to continuation and maintenance antidepressant use, the longest phase in antidepressant treatment, over 2 years and the association of adherence with future recurrence in 131 recurrently depressed patients remitted on antidepressants. LIMITATIONS: Self reported non-adherence.
RESULTS: Non-adherence ranged from 39.7% to 52.7%; 20.9% were always non-adherent, 48.4% were intermittently non-adherent and 30.8% were always adherent. Adherence rates did not significantly differ between intermittent and continuous antidepressant users (37.2% vs. 25%). Non-adherence predicted time to recurrence.
CONCLUSION: Non-adherence to continuation and maintenance antidepressant treatment in recurrent depression is frequent, like in other chronic diseases, and a potential risk of recurrence. Doctors continuously have to be aware of this problem and should keep on discussing it with their patients. Finally, as many patients don't seem to be able or willing to take AD as prescribed, alternatives to prevent relapse deserve more attention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18760488     DOI: 10.1016/j.jad.2008.07.011

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  23 in total

1.  Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.

Authors:  Amanda J Shallcross; James J Gross; Pallavi D Visvanathan; Niketa Kumar; Amy Palfrey; Brett Q Ford; Sona Dimidjian; Stephen Shirk; Jill Holm-Denoma; Kari M Goode; Erica Cox; William Chaplin; Iris B Mauss
Journal:  J Consult Clin Psychol       Date:  2015-08-10

2.  Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.

Authors:  Tina Pahlevan; Christine Ung; Zindel Segal
Journal:  Can J Psychiatry       Date:  2020-02-07       Impact factor: 4.356

3.  Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.

Authors:  Zindel V Segal; Peter Bieling; Trevor Young; Glenda MacQueen; Robert Cooke; Lawrence Martin; Richard Bloch; Robert D Levitan
Journal:  Arch Gen Psychiatry       Date:  2010-12

4.  Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs.

Authors:  Robert T Ammerman; Peter J Mallow; John A Rizzo; Frank W Putnam; Judith B Van Ginkel
Journal:  J Affect Disord       Date:  2016-11-03       Impact factor: 4.839

Review 5.  Disruption of Neural Homeostasis as a Model of Relapse and Recurrence in Late-Life Depression.

Authors:  Carmen Andreescu; Olusola Ajilore; Howard J Aizenstein; Kimberly Albert; Meryl A Butters; Bennett A Landman; Helmet T Karim; Robert Krafty; Warren D Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2019-08-07       Impact factor: 4.105

6.  Illness Beliefs, Treatment Beliefs and Information Needs as Starting Points for Patient Information: The Evaluation of an Intervention for Patients with Depression.

Authors:  Manuela Glattacker; Katja Heyduck; Cornelia Meffert; Teresa Jakob
Journal:  J Clin Psychol Med Settings       Date:  2018-09

7.  Clinical characteristics associated with therapeutic nonadherence of the patients with major depressive disorder: A report on the National Survey on Symptomatology of Depression in China.

Authors:  Qian Zhou; Zhi-Guo Wu; Yun Wang; Xiao-Hua Liu; Jun Chen; Yong Wang; You-Song Su; Chen Zhang; Dai-Hui Peng; Wu Hong; Yi-Ru Fang
Journal:  CNS Neurosci Ther       Date:  2018-07-11       Impact factor: 5.243

8.  Behavioural activation therapy for depression in adults with non-communicable diseases.

Authors:  Eleonora Uphoff; Malini Pires; Corrado Barbui; Deepa Barua; Rachel Churchill; Doriana Cristofalo; David Ekers; Edward Fottrell; Papiya Mazumdar; Marianna Purgato; Rusham Rana; Judy Wright; Najma Siddiqi
Journal:  Cochrane Database Syst Rev       Date:  2020-08-06

9.  Can a one-item mood scale do the trick? Predicting relapse over 5.5-years in recurrent depression.

Authors:  Gerard D van Rijsbergen; Claudi L H Bockting; Matthias Berking; Maarten W J Koeter; Aart H Schene
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

10.  Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.

Authors:  Marloes J Huijbers; Jan Spijker; A Rogier T Donders; Digna J F van Schaik; Patricia van Oppen; Henricus G Ruhé; Marc B J Blom; Willem A Nolen; Johan Ormel; Gert Jan van der Wilt; Willem Kuyken; Philip Spinhoven; Anne E M Speckens
Journal:  BMC Psychiatry       Date:  2012-08-27       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.